255 related articles for article (PubMed ID: 24789460)
1. Additive effects of EGF and IL-1β regulate tumor cell migration and invasion in gastric adenocarcinoma via activation of ERK1/2.
Han J; Xie Y; Lan F; Yu Y; Liu W; Chen J; Zheng F; Ouyang X; Lin X; Lin Y; Huang Q; Wang L; Tan J
Int J Oncol; 2014 Jul; 45(1):291-301. PubMed ID: 24789460
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor (EGF) and interleukin (IL)-1β synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion.
Ma L; Lan F; Zheng Z; Xie F; Wang L; Liu W; Han J; Zheng F; Xie Y; Huang Q
Mol Cancer; 2012 Oct; 11():79. PubMed ID: 23083134
[TBL] [Abstract][Full Text] [Related]
3. IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9.
Huang Q; Lan F; Wang X; Yu Y; Ouyang X; Zheng F; Han J; Lin Y; Xie Y; Xie F; Liu W; Yang X; Wang H; Dong L; Wang L; Tan J
Mol Cancer; 2014 Jan; 13():18. PubMed ID: 24479681
[TBL] [Abstract][Full Text] [Related]
4. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
[TBL] [Abstract][Full Text] [Related]
5. IL-5-induced migration via ERK1/2-mediated MMP-9 expression by inducing activation of NF-κB in HT1376 cells.
Lee EJ; Park SS; Kim WJ; Moon SK
Oncol Rep; 2012 Sep; 28(3):1084-90. PubMed ID: 22710862
[TBL] [Abstract][Full Text] [Related]
6. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
[TBL] [Abstract][Full Text] [Related]
7. IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression.
Lin CC; Kuo CT; Cheng CY; Wu CY; Lee CW; Hsieh HL; Lee IT; Yang CM
Cell Signal; 2009 Nov; 21(11):1652-62. PubMed ID: 19616091
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression.
Lee EJ; Lee SJ; Kim S; Cho SC; Choi YH; Kim WJ; Moon SK
Cell Signal; 2013 Oct; 25(10):2025-38. PubMed ID: 23770289
[TBL] [Abstract][Full Text] [Related]
9. CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation.
Han H; Du B; Pan X; Liu J; Zhao Q; Lian X; Qian M; Liu M
Mol Cancer Res; 2010 Nov; 8(11):1477-88. PubMed ID: 21047770
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
11. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
12. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling.
Kwon GT; Cho HJ; Chung WY; Park KK; Moon A; Park JH
J Nutr Biochem; 2009 Sep; 20(9):663-76. PubMed ID: 18824345
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells.
Ikari A; Sanada A; Okude C; Sawada H; Yamazaki Y; Sugatani J; Miwa M
J Cell Physiol; 2010 Mar; 222(3):481-7. PubMed ID: 19937979
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway.
Tsai PC; Hsieh CY; Chiu CC; Wang CK; Chang LS; Lin SR
Toxicon; 2012 Oct; 60(5):734-43. PubMed ID: 22683533
[TBL] [Abstract][Full Text] [Related]
15. Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity.
Cardoso AP; Pinto ML; Pinto AT; Oliveira MI; Pinto MT; Gonçalves R; Relvas JB; Figueiredo C; Seruca R; Mantovani A; Mareel M; Barbosa MA; Oliveira MJ
Oncogene; 2014 Apr; 33(16):2123-33. PubMed ID: 23644655
[TBL] [Abstract][Full Text] [Related]
16. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
17. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
Furuhashi S; Sugita H; Takamori H; Horino K; Nakahara O; Okabe H; Miyake K; Tanaka H; Beppu T; Baba H
Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of epidermal growth factor and hepatocyte growth factor on human ovarian cancer cell invasion and migration: role of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.
Zhou HY; Pon YL; Wong AS
Endocrinology; 2007 Nov; 148(11):5195-208. PubMed ID: 17673518
[TBL] [Abstract][Full Text] [Related]
19. ERK/MAPK pathways play critical roles in EGFR ligands-induced MMP1 expression.
Park S; Jung HH; Park YH; Ahn JS; Im YH
Biochem Biophys Res Commun; 2011 Apr; 407(4):680-6. PubMed ID: 21440529
[TBL] [Abstract][Full Text] [Related]
20. Allyl isothiocyanate inhibits cell metastasis through suppression of the MAPK pathways in epidermal growth factor‑stimulated HT29 human colorectal adenocarcinoma cells.
Lai KC; Lu CC; Tang YJ; Chiang JH; Kuo DH; Chen FA; Chen IL; Yang JS
Oncol Rep; 2014 Jan; 31(1):189-96. PubMed ID: 24270601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
